As the post-pandemic world of work continues to evolve, so do recruiters’ strategies and tools for finding and engaging top talent. In 2023, we are seeing these seven trends:1. Employer branding is becoming an increasingly important factor in the recruitment…
HOME > TOP STORIES
TOP STORIES
-
BUSINESS Pfizer Japan to Create New Unit for its Innovative Drug Business in December
August 22, 2014
-
ACADEMIA Kyoto University, Astellas Aim to Develop Immunological Disease Cures, 11 Target Molecules Now under Screening
August 21, 2014
-
BUSINESS MTPC, AZ Ink Research Collaboration Deal in Diabetic Nephropathy
August 21, 2014
-
BUSINESS Japan to See Grueling Battle for Free-Price Viagra Generics
August 20, 2014
-
BUSINESS Pfizer Reveals First Doctor Payments amid Delays in Disclosure
August 19, 2014
-
BUSINESS Genzyme Japan Appoints Former Bausch & Lomb Japan President Ashikaga as Its New President
August 18, 2014
-
REGULATORY 148 Blopress Generics OKed, Competition with AGs Likely upon December Listing
August 15, 2014
-
REGULATORY PMDA Will Prosper by Promoting Review Work, Research, and Training Together: Chief Executive
August 13, 2014
-
ORGANIZATION Fair Discussions Necessary for Full Introduction of New Drug Development Premium: Chuikyo Member
August 12, 2014
-
BUSINESS Asahi Kasei Pharma Aims to Achieve Sales Target of 100 Billion Yen in FY2015 Despite Debut of Flivas Generics: President
August 11, 2014
-
BUSINESS Linical Aims to Become “One-Stop” CRO for Global Clinical Trials
August 8, 2014
-
BUSINESS Daiwa Corporate Investment Establishes Venture Capital Firm Specializing in Biopharmaceuticals; Sights Set on Seeds of University Origin
August 7, 2014
-
REGULATORY MHLW to Survey Rate of Generic Drug Use Under High-Cost Healthcare System; Regulatory Reform Council Concerned that System Provides Little Incentive to Use Generics
August 6, 2014
-
ACADEMIA JSH to Adopt Tougher COI Rule after Panel Said Novartis’s Involvement in SIGN Trial Should Have Been Disclosed at Conference
August 5, 2014
-
BUSINESS Development of Antibody Drugs Accelerating in the Field of Asthma; First New Option Could Be Available as Early as 2016
August 5, 2014
-
REGULATORY MHLW to Fund Research Aimed at Obtaining Additional Indications for Intractable and Orphan Diseases for Existing Drugs
August 4, 2014
-
REGULATORY PAFSC First Committee Backs Approval of MSD’s Insomnia Treatment
August 4, 2014
-
REGULATORY Improvement Order Issued to Novartis over Delayed ADR Reporting
August 1, 2014
-
BUSINESS Nissan Chemical Files Livalo Patent Suit against Sawai in US
July 31, 2014
-
REGULATORY Regulatory Review Trend in Japan Signals Pharmas’ Shift to Cancer Drugs: Jiho Tally
July 30, 2014
ページ
Novo Nordisk’s weight-loss medication Wegovy (semaglutide) was approved in Japan in March. While it skipped the May round of reimbursement listing, physicians eagerly await the arrival of what would be the first new obesity drug in three decades. Other companies…
Japan’s health ministry on April 27 presented an outline of a report to be compiled next month by its key…
A key Japanese reimbursement policy panel on December 16 approved the government-backed plan for the FY2023 “off-year” drug price revision.…
Authorized generic (AG) strategies taken by innovative drug makers might help soften the impact of generic competition in their businesses but such tactics might also accelerate the application of “G1”/“G2” price cuts for their off-patent brand-name medicines, a Jiho tally…
Japan’s health ministry announced new NHI prices to be applied in April under the FY2022 drug price revision in the official gazette on March 4, with the earlier application of so-called “G1” price cuts to be implemented for the first…